Middle East Healthcare Company vs Dallah Healthcare Co.
A head-to-head of Middle East Healthcare Company (4009) and Dallah Healthcare Co. (4004) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4009 | 4004 |
|---|---|---|
| Market Cap | 3.13B SAR | 10.78B SAR |
| P/E (TTM) | 9.71 | 20.02 |
| Forward P/E | 8.52 | 20.80 |
| P/S | 1.00 | 2.67 |
| P/B | 1.54 | 2.64 |
| EV/EBITDA | — | 20.79 |
| Dividend Yield | 1.47% | 1.79% |
| Profit Margin | 5.34% | 11.15% |
| Gross Margin | 37.39% | 35.71% |
| Operating Margin | 12.67% | 15.40% |
| Revenue Growth (YoY) | +4.29% | +21.68% |
| FCF Yield | 9.73% | -0.21% |
| Debt / Equity | 123.07 | 94.09 |
| Current Ratio | 1.48 | 1.20 |
Which is better: Middle East Healthcare Company or Dallah Healthcare Co.?
- ✓Larger by market cap: Dallah Healthcare Co.
- ✓Cheaper valuation (lower P/E): Middle East Healthcare Company
- ✓Higher dividend yield: Dallah Healthcare Co.
- ✓More profitable (net margin): Dallah Healthcare Co.
- ✓Faster revenue growth: Dallah Healthcare Co.
- ✓Higher free-cash-flow yield: Middle East Healthcare Company
Across 12 available metrics, Middle East Healthcare Company leads 7–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Middle East Healthcare Company with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.